Oramed Pharmaceuticals Total Long-Term Assets 2011-2024 | ORMP
Oramed Pharmaceuticals total long-term assets from 2011 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
| Oramed Pharmaceuticals Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $12 |
| 2023 | $58 |
| 2022 | $5 |
| 2021 | $30 |
| 2021 | $33 |
| 2020 | $4 |
| 2019 | $1 |
| 2018 | $16 |
| 2017 | $18 |
| 2016 | $12 |
| 2015 | $9 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| Oramed Pharmaceuticals Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $12 |
| 2024-09-30 | $22 |
| 2024-06-30 | $31 |
| 2024-03-31 | $27 |
| 2023-12-31 | $58 |
| 2023-09-30 | $55 |
| 2023-06-30 | $5 |
| 2023-03-31 | $5 |
| 2022-12-31 | $5 |
| 2022-09-30 | $4 |
| 2022-06-30 | $27 |
| 2022-03-31 | $29 |
| 2021-12-31 | $30 |
| 2021-11-30 | $30 |
| 2021-09-30 | |
| 2021-08-31 | $33 |
| 2021-06-30 | |
| 2021-05-31 | $8 |
| 2021-03-31 | |
| 2021-02-28 | $4 |
| 2020-11-30 | $5 |
| 2020-08-31 | $4 |
| 2020-05-31 | $5 |
| 2020-02-29 | $0 |
| 2019-11-30 | $0 |
| 2019-08-31 | $1 |
| 2019-05-31 | $11 |
| 2019-02-28 | $12 |
| 2018-11-30 | $14 |
| 2018-08-31 | $16 |
| 2018-05-31 | $11 |
| 2018-02-28 | $17 |
| 2017-11-30 | $22 |
| 2017-08-31 | $18 |
| 2017-05-31 | $13 |
| 2017-02-28 | $12 |
| 2016-11-30 | $14 |
| 2016-08-31 | $12 |
| 2016-05-31 | $11 |
| 2016-02-29 | $12 |
| 2015-11-30 | $9 |
| 2015-08-31 | $9 |
| 2015-05-31 | $5 |
| 2015-02-28 | $5 |
| 2014-11-30 | $0 |
| 2014-08-31 | $0 |
| 2014-05-31 | $7 |
| 2014-02-28 | $0 |
| 2013-11-30 | $0 |
| 2013-08-31 | $0 |
| 2013-05-31 | $0 |
| 2013-02-28 | $0 |
| 2012-12-31 | |
| 2012-11-30 | $0 |
| 2012-08-31 | $0 |
| 2012-05-31 | $0 |
| 2012-02-29 | $0 |
| 2011-11-30 | $0 |
| 2011-09-30 | $0 |
| 2011-08-31 | $0 |
| 2011-06-30 | |
| 2011-05-31 | |
| 2011-03-31 | |
| 2011-02-28 | |
| 2010-12-31 | |
| 2010-11-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.095B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||